Biotechnology News and Research

RSS

New technology systematically identifies drug targets in living animals

Developing new medicines and understanding how they target specific organs often gives a crucial advantage in the fight against human diseases.

21 Jan 2020

Genetically engineered mosquitoes halt Dengue spread

A new study published in the journal PLOS Pathogens in January 2020 reports the development of mosquitoes that have been genetically modified to resist infection by several types of the dengue virus. This is the first time ever that all types of the virus have been targeted by the engineering of the mosquito DNA. Covering all virus types is essential to achieve proper disease control.

16 Jan 2020

New method for detection of microcystins and nodularin in human urine

Blooms of toxin-producing algae exploded in both fresh and salt water ecosystems in southern Florida during the summer months of 2018, impacting wildlife and humans living in these marine environments.

16 Jan 2020

Research collaboration reveals potential treatment option for incurable blood cancers

Today, OncoTartis, Inc. and Children's Cancer Institute jointly announced the publication of two research manuscripts in a leading onco-hematological journal Leukemia, both devoted to the OncoTartis' clinical drug candidate OT-82.

16 Jan 2020

Nicoya gains series A funding for digital drug discovery program

Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, announced today that it has raised $10 million in Series A financing.

From Nicoya Lifesciences 15 Jan 2020

New tool could speed up neuroscience research into pheromones

Researchers at Worcester Polytechnic Institute have developed a tool to identify molecular receptors in worms that are involved in sensing pheromones related to mating, an advance that could speed up neuroscience research into pheromones by eliminating months of work.

14 Jan 2020

Bath scientists identify promising route to develop new treatments for skin cancer

A promising route to develop new treatments for skin cancer has been identified by University of Bath scientists, who have found a molecule that suppresses melanoma tumor growth.

14 Jan 2020

Insilico, Pfizer to jointly explore novel data and AI system for potential therapeutic targets

Insilico Medicine is pleased to announce that it has entered into a research collaboration with Pfizer Inc. to utilize Insilico's machine learning technology and proprietary Pandomics Discovery Platform with the aim of identifying real-world evidence for potential therapeutic targets implicated in a variety of diseases.

14 Jan 2020

Human liver manages to stay alive outside the body for a week

Scientists from University Hospital Zurich, ETH Zurich, Wyss Zurich and the University of Zurich have managed to keep human livers alive for a week outside the body using machines. If successful on large scale trials, this could be a breakthrough for organ transplants and donor organs could be stored outside the body for longer, speculate researchers.

13 Jan 2020

Study of glycobiology and glycan diagnostics in personalized medicine featured in OMICS special issue

An in-depth look at the science of glycobiology and glycan diagnostics, and their promise in personalized medicine in the current post-genomic era are featured in a special issue of OMICS: A Journal of Integrative Biology, the peer-reviewed interdisciplinary journal published by Mary Ann Liebert, Inc., publishers.

13 Jan 2020

Using caffeine to study how the brain processes information

Researchers are using caffeine to study how the brain processes information, and a new study shows the effectiveness of this approach.

13 Jan 2020

Insilico Medicine to showcase results of generative biology target ID system

Insilico Medicine, a biotechnology company developing end-to-end drug discovery pipelines utilizing the next-generation artificial intelligence, to present new results of its generative biology pipeline resulting in novel targets in liver disease.

12 Jan 2020

New tool judges accuracy of computer predictions of tumor’s genetic diversity

Cancers are often made up of many cells which vary genetically to each other. These genetic differences mean the cancer may be particularly susceptible or resistant to a given treatment. As a result, identifying these variations can help clinicians decide which treatment is most likely to be successful for a specific patient.

10 Jan 2020

New framework developed to estimate the growth of individual cancer

Cancer is a disease of evolution: cancer cells continually grow and change, and new mutations allow them to spread, even as treatments have continued to improve.

10 Jan 2020

Insilico and Beiersdorf use next-generation AI technology in skin research

Beiersdorf and Insilico Medicine, an artificial intelligence company developing end to end drug discovery pipelines, announced today that they are entering a collaboration to jointly discover novel, safe bioactive ingredients for a specific skin indication at an unparalleled pace, that will serve as the basis for developing appropriate skincare products.

8 Jan 2020

Researchers uncover a response key to the survival of Mycoplasma genitalium in urogenital tract

A study led by an IBB-UAB research team has managed to identify the mechanisms by which the sexually transmitted bacterium Mycoplasma genitalium (Mge) can persist in conditions with very limited availability of metals, a circumstance it must face when infecting humans.

8 Jan 2020

Mayo Clinic researchers seek radical new approach to treat cocaine addition

In a radical new approach to treat cocaine addition, researchers at the Mayo Clinic are seeking approval for first-in-human studies of a single-dose gene therapy.

7 Jan 2020

Experts release new recommendations on bedsharing to promote breastfeeding

Leading experts representing The Academy of Breastfeeding Medicine (ABM) have released new evidence-based recommendations regarding the benefits and risks of bedsharing for mother-infant pairs who have initiated breastfeeding and are in home settings.

7 Jan 2020

New extract can prevent nephrotoxicity caused by mycotoxin OTA

Today a team of researchers from the Department of Veterinary Medicine and Animal Production of the Federico II University of Naples, in collaboration with the Sbarro Health Research Organization (SHRO), at Temple University in Philadelphia, and the Department of Biotechnology at the University of Siena, Itay, has discovered the effectiveness of a new extract, of natural origin.

7 Jan 2020

ART may not be completely effective in restoring immune protection, study suggests

A study led by researchers from SUNY Downstate Health Sciences University and Oregon Health & Science University, published in the Journal of Infectious Diseases, showed that, despite successful antiretroviral therapy, antigen specific memory to vaccinations that occurred before HIV infection did not recover, even after immune reconstitution.

6 Jan 2020